545 related articles for article (PubMed ID: 10813725)
1. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
[TBL] [Abstract][Full Text] [Related]
2. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
3. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
[TBL] [Abstract][Full Text] [Related]
4. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
[TBL] [Abstract][Full Text] [Related]
5. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
[TBL] [Abstract][Full Text] [Related]
6. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.
van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ
Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184
[TBL] [Abstract][Full Text] [Related]
7. Surgical margins and local control in resection of sacral chordomas.
Ruggieri P; Angelini A; Ussia G; Montalti M; Mercuri M
Clin Orthop Relat Res; 2010 Nov; 468(11):2939-47. PubMed ID: 20635173
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.
Hobusch GM; Bodner F; Walzer S; Marculescu R; Funovics PT; Sulzbacher I; Windhager R; Panotopoulos J
World J Surg Oncol; 2016 Apr; 14():111. PubMed ID: 27091202
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of sacral chordoma: survival and prognostic factors.
Ruosi C; Colella G; Di Donato SL; Granata F; Di Salvatore MG; Fazioli F
Eur Spine J; 2015 Nov; 24 Suppl 7():912-7. PubMed ID: 26458933
[TBL] [Abstract][Full Text] [Related]
10. Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.
Yang Y; Niu X; Li Y; Liu W; Xu H
Eur Spine J; 2017 Jul; 26(7):1910-1916. PubMed ID: 27942938
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors in Surgical Patients with Chordomas of the Cervical Spine: A Study of 52 Cases from a Single Institution.
Zhou H; Jiang L; Wei F; Joeris A; Hurtado-Chong A; Kalampoki V; Rometsch E; Yu M; Wu F; Dang L; Liu X; Liu Z
Ann Surg Oncol; 2017 Aug; 24(8):2355-2362. PubMed ID: 28593502
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
[TBL] [Abstract][Full Text] [Related]
13. Current management of sacral chordoma.
Fourney DR; Gokaslan ZL
Neurosurg Focus; 2003 Aug; 15(2):E9. PubMed ID: 15350040
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in surgical resection of sacral chordoma.
Angelini A; Pala E; Calabrò T; Maraldi M; Ruggieri P
J Surg Oncol; 2015 Sep; 112(4):344-51. PubMed ID: 26238085
[TBL] [Abstract][Full Text] [Related]
15. The clinical outcome of recurrent sacral chordoma with further surgical treatment.
Yang Y; Li Y; Liu W; Xu H; Niu X
Medicine (Baltimore); 2018 Dec; 97(52):e13730. PubMed ID: 30593146
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in the operative management of dedifferentiated sacral chordomas.
Kayani B; Sewell MD; Hanna SA; Saifuddin A; Aston W; Pollock R; Skinner J; Molloy S; Briggs TW
Neurosurgery; 2014 Sep; 75(3):269-75; discussion 275. PubMed ID: 24867206
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
18. A review of the surgical management of sacral chordoma.
Kayani B; Hanna SA; Sewell MD; Saifuddin A; Molloy S; Briggs TW
Eur J Surg Oncol; 2014 Nov; 40(11):1412-20. PubMed ID: 24793103
[TBL] [Abstract][Full Text] [Related]
19. The surgical management of sacral chordomas.
Schwab JH; Healey JH; Rose P; Casas-Ganem J; Boland PJ
Spine (Phila Pa 1976); 2009 Nov; 34(24):2700-4. PubMed ID: 19910774
[TBL] [Abstract][Full Text] [Related]
20. Oncologic and functional outcome following sacrectomy for sacral chordoma.
Hulen CA; Temple HT; Fox WP; Sama AA; Green BA; Eismont FJ
J Bone Joint Surg Am; 2006 Jul; 88(7):1532-9. PubMed ID: 16818979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
